EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Athira Pharma, Inc. (ATHA) EBITDA Margin data is not available.
Income Statement Financials | |
-- |
|
$-117.67M |
|
-- |
|
-- |
|
$125.47M |
|
$-125.47M |
|
$7.79M |
|
$-117.67M |
|
$-117.67M |
|
$-117.67M |
|
$-117.67M |
|
$-117.67M |
|
$-117.67M |
|
$-125.47M |
|
$-125.91M |
|
38.02M |
|
38.02M |
|
$-3.09 |
|
$-3.09 |
|
Balance Sheet Financials | |
$154.73M |
|
$3.39M |
|
$5.52M |
|
$160.25M |
|
$28.84M |
|
-- |
|
$1.22M |
|
$30.06M |
|
$130.19M |
|
$130.19M |
|
$130.19M |
|
38.17M |
|
Cash Flow Statement Financials | |
$-100.75M |
|
$95.09M |
|
$0.49M |
|
$96.39M |
|
$91.22M |
|
$-5.17M |
|
$10.62M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
5.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
EBITDA Margin |
-- |
-- |
|
-- |
|
$-101.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-90.39% |
|
-90.39% |
|
-73.43% |
|
-90.39% |
|
$3.41 |
|
$-2.66 |
|
$-2.65 |